Primary mucosa-associated lymphoid tissue lymphoma in the midbrain: A case report

Table 1 Clinical summary of patients with primary non-dural central nervous system mucosa-associated lymphoid tissue lymphoma

Ref.	Age (yr)	Sex	Location	Presentation	Treatment	Outcome
Tu et al[13]	66	M	R, frontal	Seizures	Radiation (WBRT, dose NA)	CR
Park et al[8]	18	M	L, basal ganglia	Right-sided central facial nerve palsy, right-sided weakness, dizziness, dysarthria	Radiation (CTV = GTV + 15 mm, PTV = CTV + 5 mm; 30.6 Gy/17F)	CR
Papanicolau-Sengos et al[14]	70	M	L, posteriorputamen	Right extremity numbness, dysarthria, blurry vision	Chemotherapy (dexamethasone, temozolamide, rituximab)	SD
Schiefer et al[15]	39	F	R, frontal	Seizures	Chemotherapy (intrathecal: Methotrexate, cytarabin, dexamethasone; Intravenous: High-dose methotrexate)	SD
Aqil et al[7]	48	M	L, frontal	Seizures, memory loss	Radiation (WBRT, 24 Gy; GTV boosted 6 Gy)	CR
Ueba et al[10]	53	M	R, temporal; L, occipital; spinal cord	Recent memory disturbance, gait disturbance, urinary incontinence	Chemotherapy (high-dose methotrexate, cytoarabine)	PR

WBRT: Whole brain radiation therapy; CTV: Clinical target volume; GTV: Gross target volume; PTV: Planning target volume; CR: Complete remission; PR: Partial remission; SD: Stable disease; NA: Not available; M: Male; F: Female.